Predictions
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€2.12
27.09.23
27.09.23
-
27.09.24
27.09.24
-35.70%
30.09.23
30.09.23
Risky Investment
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.47
26.09.23
26.09.23
-
26.09.24
26.09.24
-26.87%
15.10.23
15.10.23
Could be very worthwhile Investment >20% year
Palatin Technologies Inc.
Start price
Target price
Perf. (%)
€1.81
16.09.23
16.09.23
€1.00
16.09.24
16.09.24
-22.10%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
Lower EBIT Margin than peer group
High valuation
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€5.11
16.09.23
16.09.23
€2.00
16.09.24
16.09.24
-14.09%
30.09.23
30.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
AEterna Zentaris Inc.
Start price
Target price
Perf. (%)
€2.58
16.09.23
16.09.23
€1.00
16.09.24
16.09.24
-11.84%
30.09.23
30.09.23
Ose Pharma International S.A.
Start price
Target price
Perf. (%)
€6.87
13.09.23
13.09.23
-
13.09.24
13.09.24
-27.22%
15.09.23
15.09.23
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.40
11.09.23
11.09.23
-
11.09.24
11.09.24
-22.50%
12.09.23
12.09.23
Probably not worthwhile Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€2.14
09.09.23
09.09.23
€3.00
09.09.24
09.09.24
-18.69%
16.09.23
16.09.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
High valuation
AC Immune Ltd
Start price
Target price
Perf. (%)
€3.25
04.09.23
04.09.23
-
04.09.24
04.09.24
7.86%
11.12.23
11.12.23
Could be worthwhile Investment >10% per year
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.97
03.09.23
03.09.23
-
03.09.24
03.09.24
-21.32%
13.09.23
13.09.23
Risky Investment
BioLine RX Ltd ADR
Start price
Target price
Perf. (%)
€1.97
03.09.23
03.09.23
€2.50
31.07.25
31.07.25
18.78%
06.09.23
06.09.23
Could be very worthwhile Investment >20% year
Lisata Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.94
03.09.23
03.09.23
-
03.09.24
03.09.24
1.03%
16.09.23
16.09.23
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.01
03.09.23
03.09.23
-
03.09.24
03.09.24
-19.80%
05.11.23
05.11.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Cardiff Oncology Inc.
Start price
Target price
Perf. (%)
€1.67
02.09.23
02.09.23
€17.00
02.09.24
02.09.24
-5.50%
16.09.23
16.09.23
ifa systems AG
Start price
Target price
Perf. (%)
€3.16
20.08.23
20.08.23
€0.000
20.08.24
20.08.24
-5.70%
03.09.23
03.09.23
Revenue decline/stagnation expected
Decining EBIT margin than peer group
EBIT decline/stagnation expected
High valuation
Tabula Rasa HealthCare Inc
Start price
Target price
Perf. (%)
€9.35
08.08.23
08.08.23
-
08.08.24
08.08.24
5.88%
11.12.23
11.12.23
Probably not worthwhile Investment
Bio-Gate AG
Start price
Target price
Perf. (%)
€1.28
06.08.23
06.08.23
-
06.08.24
06.08.24
-12.50%
20.08.23
20.08.23
Could be worthwhile Investment >10% per year
Top 10 in its market
Very Future proof/growth oriented business model
Significant cyclical dependencies
Shin Nippon Biomedical Laboratories Ltd.
Start price
Target price
Perf. (%)
€13.30
02.08.23
02.08.23
-
02.08.26
02.08.26
12.03%
08.08.23
08.08.23
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.37
31.07.23
31.07.23
-
25.08.26
25.08.26
-89.21%
24.11.23
24.11.23
Seelos Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.29
24.07.23
24.07.23
-
24.08.23
24.08.23
6.44%
31.07.23
31.07.23